Statement Of Income And Retained Earnings

KYORIN Pharmaceutical Co., Ltd. - Filing #7330327

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
6,013,000,000 JPY
6,679,000,000 JPY
3,059,000,000 JPY
5,123,000,000 JPY
Non-operating income
Non-operating income
735,000,000 JPY
804,000,000 JPY
93,000,000 JPY
799,000,000 JPY
Non-operating expenses
Non-operating expenses
146,000,000 JPY
66,000,000 JPY
177,000,000 JPY
94,000,000 JPY
Ordinary profit (loss)
6,602,000,000 JPY
7,417,000,000 JPY
2,975,000,000 JPY
5,827,000,000 JPY
Extraordinary income
Extraordinary income
1,404,000,000 JPY
48,537,000,000 JPY
JPY
1,979,000,000 JPY
Extraordinary losses
Extraordinary losses
987,000,000 JPY
938,000,000 JPY
0 JPY
900,000,000 JPY
Profit (loss) before income taxes
7,019,000,000 JPY
55,016,000,000 JPY
2,974,000,000 JPY
6,906,000,000 JPY
Income taxes - current
1,897,000,000 JPY
2,046,000,000 JPY
-25,000,000 JPY
2,462,000,000 JPY
Income taxes - deferred
-200,000,000 JPY
-25,000,000 JPY
-5,000,000 JPY
-279,000,000 JPY
Profit (loss)
52,995,000,000 JPY
5,322,000,000 JPY
52,995,000,000 JPY
52,995,000,000 JPY
52,995,000,000 JPY
3,005,000,000 JPY
3,005,000,000 JPY
3,005,000,000 JPY
3,005,000,000 JPY
4,723,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.